Please use this identifier to cite or link to this item:
Type: Thesis
Title: Azithromycin suppresses human osteoclast formation and activity in vitro.
Author: Gannon, Siobhan Catherine
Issue Date: 2013
School/Discipline: School of Dentistry
Abstract: Azithromycin is an antibiotic with anti-inflammatory properties used as an adjunct in the treatment of periodontitis, a common inflammatory mediated condition featuring pathologic alveolar bone resorption. The aim of this study was to determine the effect of azithromycin on human osteoclast formation and resorptive activity in vitro. Osteoclasts were generated from peripheral blood mononuclear cells stimulated with macrophage colony stimulating factor (M-CSF) and receptor activator of nuclear factor kappa B (RANK) ligand. The effects of azithromycin at concentrations ranging from 0.5 μg/mL to 40 μg/mL were tested. Osteoclast formation and activity, acidification, actin ring formation and expression of mRNA and protein encoding for key osteoclast genes were assessed. The results demonstrated that azithromycin reduced osteoclast resorptive activity at all concentrations tested with osteoclast formation being significantly reduced at the higher concentrations (20μg/mL and 40μg/mL). mRNA and protein expression of the key osteoclast transcription factor Nuclear Factor of Activated T cells (NFATc1) was significantly reduced by azithromycin at later stages of osteoclast development (day 17). Azithromycin also reduced tumour necrosis factor receptor associated factor-6 (TRAF6) mRNA expression at day 14, and cathepsin K mRNA expression at day 14 and 17. Integrin β3 and MMP-9 mRNA expression was reduced by azithromycin at day 17 in osteoclasts cultured on dentine. The osteoclast proton pump did not appear to be affected by azithromycin, however formation of the actin ring cytoskeleton was inhibited. This study demonstrates that azithromycin inhibits human osteoclast function in vitro, which may account for at least some of the beneficial clinical effects observed with azithromycin treatment in periodontitis.
Advisor: Bartold, Mark
Kardachi, Bryon Joseph Ross
Hirsch, Robert Steven
Dissertation Note: Thesis (D. Clin. Dent.) -- University of Adelaide, School of Dentistry, 2013
Keywords: azithromycin; periodontal disease; osteoclast
Appears in Collections:Research Theses

Files in This Item:
File Description SizeFormat 
01front.pdf56.04 kBAdobe PDFView/Open
02whole.pdf941.86 kBAdobe PDFView/Open
  Restricted Access
Library staff access only700.21 kBAdobe PDFView/Open
  Restricted Access
Library staff access only11.05 MBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.